Chataway, J;
Martin, K;
Barrell, K;
Sharrack, B;
Stolt, P;
Wraith, D;
for the ATX-MS 1467 Study Group;
(2018)
Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis.
Neurology
, 90
(11)
, Article e962. 10.1212/WNL.0000000000005118.